Anthony Y. Sun - Feb 10, 2022 Form 4 Insider Report for Zentalis Pharmaceuticals, Inc. (ZNTL)

Signature
By: /s/ Melissa B. Epperly, Attorney-in-Fact for Anthony Y. Sun
Stock symbol
ZNTL
Transactions as of
Feb 10, 2022
Transactions value $
-$237,733
Form type
4
Date filed
2/14/2022, 08:08 PM
Previous filing
Feb 3, 2022
Next filing
Mar 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZNTL Common Stock Award $0 +50.4K +4.3% $0.00 1.22M Feb 10, 2022 Direct F1
transaction ZNTL Common Stock Sale -$211K -4.21K -0.34% $50.16 1.22M Feb 14, 2022 Direct F2, F3
transaction ZNTL Common Stock Sale -$26.6K -525 -0.04% $50.75 1.22M Feb 14, 2022 Direct F2, F4
holding ZNTL Common Stock 104K Feb 10, 2022 By Spouse
holding ZNTL Common Stock 974K Feb 10, 2022 By Essex Group International, LLC
holding ZNTL Common Stock 214K Feb 10, 2022 By Hao Bao Zi Trust LLC F5
holding ZNTL Common Stock 125K Feb 10, 2022 By Hao Jiao Zi Trust LLC F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZNTL Stock Option (Right to Buy) Award $0 +118K $0.00 118K Feb 10, 2022 Common Stock 118K $52.61 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest in substantially equal annual installments over a four year period following the grant date.
F2 The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading arrangement adopted by the Reporting Person. Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units.
F3 The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $49.58 to $50.56. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $50.58 to $50.81. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 Represents shares nominally held by Hao Bao Zi Trust LLC on behalf of the Hao Bao Zi Trust (the "Trust"), the sole member of Hao Bao Zi Trust LLC. The Reporting Person's spouse is the investment adviser with sole power to make investment decisions regarding the securities held by the Trust. The Reporting Person disclaims beneficial ownership of the securities held by Hao Bao Zi Trust LLC except to the extent of his pecuniary interest therein, if any.
F6 Represents shares nominally held by Hao Jiao Zi Trust LLC on behalf of the Hao Jiao Zi Trust (the "Trust"), the sole member of Hao Jiao Zi Trust LLC. The Reporting Person's spouse is the investment adviser with sole power to make investment decisions regarding the securities held by the Trust. The Reporting Person disclaims beneficial ownership of the securities held by Hao Jiao Zi Trust LLC except to the extent of his pecuniary interest therein, if any.
F7 The option vests and becomes exercisable in 48 substantially equal monthly installments following the grant date.